Advertisement

PharmacoEconomics & Outcomes News

, Volume 844, Issue 1, pp 19–19 | Cite as

HPV vaccination through age 45 in the US: small benefit, high cost

Clinical study
  • 3 Downloads

Reference

  1. Laprise JF, et al. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. Annals of Internal Medicine : 10 Dec 2019. Available from: URL: http://doi.org/10.7326/M19-1182

Copyright information

© Springer International Publishing AG 2020

Personalised recommendations